Repligen Corp D
D
RGEN
176.660
USD
-2.12
(-1.19%)
مغلق
آخر تحديث: · متأخرة 15 دقيقة
حجم التداول
47,186
الربح لكل سهم
2
العائد الربحي
-
P/E
242
حجم السوق
11,216,207,881
العنوان: Repligen Corp
القطاع: الرعاية الصحية
الصناعة: Medical Instruments & Supplies
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, and other life science companies. It sells four main product categories: filtration and fluid management is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia-Pacific contribute about 44%, 37%,and 19% of revenue, respectively.

